(S)-[[2-(4-氨基-2-氧-1(2H)嘧啶基)-1-(羟基甲基)乙氧基]甲基]膦酸; [1-(4-氨基-2-氧代嘧啶-1-基)-3-羟基丙烷-2-基]氧甲基膦酸; 培哚普利叔丁胺盐; 无水西多福韦
Cidovir (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine HPMPC Vistide; Phosphonic acid, [[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-; ({[(2S)-1-(4-Amino-2-oxo-1(2H)-pyrimidinyl)-3-hydroxy-2-propanyl]oxy}methyl)phosphonic acid; Vistide; ({[(2S)-1-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid; Cidofovir; (S)-(3-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid; (S)-[[2-(4-Amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic Acid; MFCD00866936; Cidofovir hydrate; GS-504; Cidofovir (anhydrous); (S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine; (S)-HPMPC; UNII-768M1V522C; Phosphonic acid, ((2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-, (S)-; ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid; {[2-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-(hydroxymethyl)ethoxy]methyl}phosphonic acid; Cidofovir anhydrous
room temp
1、 摩尔折射率:58.29 2、 摩尔体积(cm3/mol):158.6 3、 等张比容(90.2K):489.2 4、 表面张力(dyne/cm):90.5 5、 极化率(10-24cm3):23.10
1.疏水参数计算参考值(XlogP):-3.6 2.氢键供体数量:4 3.氢键受体数量:6 4.可旋转化学键数量:6 5.互变异构体数量:3 6.拓扑分子极性表面积146 7.重原子数量:18 8.表面电荷:0 9.复杂度:417 10.同位素原子数量:0 11.确定原子立构中心数量:1 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1
1.性状:蓬松的白色粉末 2.熔点(ºC):260